ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ABBV AbbVie Inc

163.79
2.98 (1.85%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
2.98 1.85% 163.79 10:00:00
Open Price Low Price High Price Close Price Previous Close
161.85 160.74 164.25 163.79 160.81
more quote information »

Recent News

Date Time Source Heading
26/4/202421:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/4/202421:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/4/202422:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/4/202422:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/4/202422:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/4/202421:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/4/202422:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/4/202423:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/4/202423:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/4/202422:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/3/202422:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
26/3/202402:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/3/202423:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/3/202423:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
23/3/202406:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/3/202423:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
08/3/202400:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
07/3/202400:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
06/3/202409:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202404:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
06/3/202400:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/3/202423:00PRNUSDragonfly has Received Milestone Payment Following Dosing of..
02/3/202411:53EDGAR2Form 144 - Report of proposed sale of securities
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202409:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202408:20EDGAR2Form 144 - Report of proposed sale of securities
01/3/202410:06EDGAR2Form 144 - Report of proposed sale of securities
01/3/202409:33EDGAR2Form 144 - Report of proposed sale of securities
01/3/202408:04EDGAR2Form 144 - Report of proposed sale of securities
28/2/202416:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
28/2/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202400:00GLOBEHealis Therapeutics' asset CKDB-501A shares Phase III..
27/2/202423:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
27/2/202409:08EDGAR2Form 8-K - Current report
26/2/202422:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/2/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202408:04EDGAR2Form 144 - Report of proposed sale of securities
23/2/202400:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
22/2/202410:00EDGAR2Form 144 - Report of proposed sale of securities
22/2/202400:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/2/202400:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
21/2/202409:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock